O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Completed · Phase 1

Conditions studied: Brain and Central Nervous System Tumors

In brief

Phase I trial to study the effectiveness of O6-benzylguanine and carmustine in treating children who have refractory CNS tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Key facts

Study ID
NCT00003765
Run by
National Cancer Institute (NCI)
People needed
36
Starts
1999-05-01
Last updated by the study team
2013-02-05

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.